Patents by Inventor Robert Andrew Falconer

Robert Andrew Falconer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING CANCER USING COMPOUNDS CONTAINING A VASCULAR DISRUPTING AGENT
    Publication number: 20200316212
    Abstract: The present invention relates to prodrugs of vascular disrupting agents comprising a vascular disrupting agent (VDA) associated with a MMP proteolytic cleavage site and to the use of such prodrugs in the targeted treatment of cancer.
    Type: Application
    Filed: June 19, 2020
    Publication date: October 8, 2020
    Inventors: Robert Andrew Falconer, Jason Gill, Jennifer Xavier, Paul Loadman, Michael Bibby, Laurence Patterson
  • Methods of treating cancer using compounds containing a vascular disrupting agent
    Patent number: 9937267
    Abstract: The present invention relates to prodrugs of vascular disrupting agents comprising a vascular disrupting agent (VDA) associated with a MMP proteolytic cleavage site and to the use of such prodrugs in the targeted treatment of cancer.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: April 10, 2018
    Assignee: Incanthera Ltd
    Inventors: Robert Andrew Falconer, Jason Gill, Jennifer Xavier, Paul Loadman, Michael Bibby, Laurence Patterson
  • Methods Of Treating Cancer Using Compounds Containing A Vascular Disrupting Agent
    Publication number: 20170266307
    Abstract: The present invention relates to prodrugs of vascular disrupting agents comprising a vascular disrupting agent (VDA) associated with a MMP proteolytic cleavage site and to the use of such prodrugs in the targeted treatment of cancer.
    Type: Application
    Filed: October 19, 2016
    Publication date: September 21, 2017
    Inventors: Robert Andrew Falconer, Jason Gill, Jennifer Xavier, Paul Loadman, Michael Bibby, Laurence Patterson
  • Compounds
    Publication number: 20150196658
    Abstract: The present invention relates to prodrugs of vascular disrupting agents comprising a vascular disrupting agent (VDA) associated with a MMP proteolytic cleavage site and to the use of such prodrugs in the targeted treatment of cancer.
    Type: Application
    Filed: November 25, 2014
    Publication date: July 16, 2015
    Inventors: Robert Andrew Falconer, Jason Gill, Jennifer Xavier, Paul Loadman, Michael Bibby, Laurence Patterson
  • COMPOUNDS
    Publication number: 20110275554
    Abstract: The present invention relates to prodrugs of vascular disrupting agents comprising a vascular disrupting agent (VDA) associated with a MMP proteolytic cleavage site and to the use of such prodrugs in the targeted treatment of cancer.
    Type: Application
    Filed: October 20, 2009
    Publication date: November 10, 2011
    Applicant: The University of Bradford
    Inventors: Robert Andrew Falconer, Jason Gill, Jennifer Atkinson, Paul Loadman, Michael Bibby, Laurence Patterson